TY - JOUR AU - Leader, S. AU - Kohlhase, K. PY - 2002 DA - 2002// TI - Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999 JO - Pediatr Infect Dis J VL - 21 UR - https://doi.org/10.1097/00006454-200207000-00005 DO - 10.1097/00006454-200207000-00005 ID - Leader2002 ER - TY - JOUR AU - Leader, S. AU - Kohlhase, K. PY - 2003 DA - 2003// TI - Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000 JO - J Pediatr VL - 143 UR - https://doi.org/10.1067/S0022-3476(03)00510-9 DO - 10.1067/S0022-3476(03)00510-9 ID - Leader2003 ER - TY - JOUR AU - Shay, D. K. AU - Holman, R. C. AU - Newman, R. D. AU - Liu, L. L. AU - Stout, J. W. AU - Anderson, L. J. PY - 1999 DA - 1999// TI - Bronchiolitis-associated hospitalizations among US children, 1980–1996 JO - JAMA VL - 282 UR - https://doi.org/10.1001/jama.282.15.1440 DO - 10.1001/jama.282.15.1440 ID - Shay1999 ER - TY - JOUR AU - Parrott, R. H. AU - Kim, H. W. AU - Arrobio, J. O. AU - Hodes, D. S. AU - Murphy, B. R. AU - Brandt, C. D. AU - Camargo, E. AU - Chanock, R. M. PY - 1973 DA - 1973// TI - Epidemiology of respiratory syncytial virus infections in Washington DC, II JO - Am J Epidemiol VL - 98 ID - Parrott1973 ER - TY - CHAP PY - 1986 DA - 1986// TI - The prospects for immunizing against respiratory syncytial virus BT - New Vaccine Development: Establishing Priorities. Volume 2 PB - National Academy Press CY - Washington, DC ID - ref5 ER - TY - JOUR AU - Hall, C. B. PY - 2001 DA - 2001// TI - Respiratory syncytial virus and parainfluenza virus JO - N Engl J Med VL - 344 UR - https://doi.org/10.1056/NEJM200106213442507 DO - 10.1056/NEJM200106213442507 ID - Hall2001 ER - TY - JOUR PY - 1998 DA - 1998// TI - Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants JO - Pediatrics VL - 102 UR - https://doi.org/10.1542/peds.102.3.531 DO - 10.1542/peds.102.3.531 ID - ref7 ER - TY - JOUR PY - 2009 DA - 2009// TI - Policy statement – modified recommendations for use of Palivizumab for prevention of respiratory syncytial virus infections JO - Pediatrics VL - 124 UR - https://doi.org/10.1542/peds.2009-1807 DO - 10.1542/peds.2009-1807 ID - ref8 ER - TY - JOUR AU - Wilkesmann, A. AU - Ammann, R. A. AU - Schildgen, O. AU - Eis-Hübinger, A. M. AU - Müller, A. AU - Seidenberg, J. AU - Stephan, V. AU - Rieger, C. AU - Herting, E. AU - Wygold, T. AU - Hornschuh, F. AU - Groothuis, J. R. AU - Simon, A. PY - 2007 DA - 2007// TI - Hospitalized children with respiratory syncytial virus infection and neuromuscular impairment face an increased risk of a complicated course JO - Pediatr Infect Dis J VL - 26 UR - https://doi.org/10.1097/INF.0b013e31805d01e3 DO - 10.1097/INF.0b013e31805d01e3 ID - Wilkesmann2007 ER - TY - JOUR AU - Feltes, T. F. AU - Cabalka, A. J. AU - Meissner, C. AU - Piazza, F. M. AU - Carlin, D. A. AU - Top, F. H. AU - Connor, E. M. AU - Sondheimer, H. PY - 2003 DA - 2003// TI - Palivizumab prophylaxis hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease JO - J Pediatr VL - 143 UR - https://doi.org/10.1067/S0022-3476(03)00454-2 DO - 10.1067/S0022-3476(03)00454-2 ID - Feltes2003 ER - TY - STD TI - Health Insurance Portability and Accountability Act of 1996. Public law 104–191, 104th Congress. US Department of Health and Human Services. 1996, http://www.cms.hhs.gov/HIPAAGenInfo/Downloads/HIPAALaw.pdf, UR - http://www.cms.hhs.gov/HIPAAGenInfo/Downloads/HIPAALaw.pdf ID - ref11 ER - TY - JOUR AU - Palmer, L. AU - Hall, C. B. AU - Katkin, J. P. AU - Shi, N. AU - Masaquel, A. S. AU - McLaurin, K. K. AU - Mahadevia, P. J. PY - 2010 DA - 2010// TI - Healthcare costs within a year of respiratory syncytial virus among Medicaid infants JO - Pediatr Pulmonol VL - 45 UR - https://doi.org/10.1002/ppul.21244 DO - 10.1002/ppul.21244 ID - Palmer2010 ER - TY - JOUR AU - Palmer, L. AU - Hall, C. B. AU - Katkin, J. P. AU - Shi, N. AU - Masaquel, A. S. AU - McLaurin, K. K. AU - Mahadevia, P. J. PY - 2011 DA - 2011// TI - Respiratory outcomes, utilization and costs 12 months following a respiratory syncytial virus diagnosis among commercially insured late-preterm infants JO - Curr Med Res Opin VL - 27 UR - https://doi.org/10.1185/03007995.2010.542744 DO - 10.1185/03007995.2010.542744 ID - Palmer2011 ER - TY - JOUR AU - Flaherman, V. AU - Li, S. AU - Ragins, A. AU - Masaquel, A. AU - Kipnis, P. AU - Escobar, G. J. PY - 2010 DA - 2010// TI - Respiratory syncytial virus testing during bronchiolitis episodes of care in an integrated health care delivery system: a retrospective cohort study JO - Clin Ther VL - 32 UR - https://doi.org/10.1016/S0149-2918(10)80025-6 DO - 10.1016/S0149-2918(10)80025-6 ID - Flaherman2010 ER - TY - JOUR AU - Langkamp, D. L. AU - Hlavin, S. M. PY - 2001 DA - 2001// TI - Factors predicting compliance with palivizumab in high-risk infants JO - Am J Perinatol VL - 18 UR - https://doi.org/10.1055/s-2001-17860 DO - 10.1055/s-2001-17860 ID - Langkamp2001 ER - TY - JOUR AU - Frogel, M. AU - Nerwen, C. AU - Cohen, A. AU - Van Veldhuisen, P. AU - Harrington, M. AU - Boron, M. PY - 2008 DA - 2008// TI - Prevention of hospitalization due to respiratory syncytial virus: results from the Palivizumab Outcomes Registry JO - J Perinatol VL - 28 UR - https://doi.org/10.1038/jp.2008.28 DO - 10.1038/jp.2008.28 ID - Frogel2008 ER - TY - JOUR AU - Hampp, C. AU - Saidi, A. S. AU - Winterstein, A. G. PY - 2010 DA - 2010// TI - Palivizumab utilization and compliance: trends in respiratory syncytial virus prophylaxis in Florida JO - J Pediatr VL - 156 UR - https://doi.org/10.1016/j.jpeds.2009.12.016 DO - 10.1016/j.jpeds.2009.12.016 ID - Hampp2010 ER - TY - JOUR AU - Golombek, S. G. AU - Berning, F. AU - Lagamma, E. F. PY - 2004 DA - 2004// TI - Compliance with prophylaxis for respiratory syncytial virus infection in a home setting JO - Pediatr Infect Dis J VL - 23 UR - https://doi.org/10.1097/00006454-200404000-00008 DO - 10.1097/00006454-200404000-00008 ID - Golombek2004 ER - TY - JOUR AU - Anderson, K. S. AU - Mullally, V. M. AU - Fredrick, L. M. AU - Campbell, A. L. PY - 2009 DA - 2009// TI - Compliance with RSV prophylaxis: global physicians’ perspectives JO - Patient Prefer Adherence VL - 3 UR - https://doi.org/10.2147/PPA.S5696 DO - 10.2147/PPA.S5696 ID - Anderson2009 ER - TY - JOUR AU - Frogel, M. P. AU - Stewart, D. L. AU - Hoopes, M. AU - Fernandes, A. W. AU - Mahedevia, P. J. PY - 2010 DA - 2010// TI - A systematic review of compliance with palivizumab administration for RSV immunoprophylaxis JO - J Manag Care Pharm VL - 16 ID - Frogel2010 ER - TY - JOUR AU - Diehl, J. L. AU - Daw, J. R. AU - Coley, K. C. AU - Rayburg, R. PY - 2010 DA - 2010// TI - Medical utilization associated with palivizumab compliance in a commercial and managed Medicaid health plan JO - J Manag Care Pharm VL - 16 ID - Diehl2010 ER - TY - JOUR AU - Mansbach, J. AU - Kunz, S. AU - Acholonu, U. AU - Clark, S. AU - Camargo, C. A. PY - 2007 DA - 2007// TI - Evaluation of compliance with palivizumab recommendations in a multicenter study of young children presenting to the emergency department with bronchiolitis JO - Pediatr Emerg Care VL - 23 UR - https://doi.org/10.1097/01.pec.0000278406.75815.d3 DO - 10.1097/01.pec.0000278406.75815.d3 ID - Mansbach2007 ER - TY - JOUR AU - Robbie, G. J. AU - Zhao, L. AU - Mondick, J. AU - Losonsky, G. AU - Roskos, L. K. PY - 2012 DA - 2012// TI - Population pharmacokinetics of palivizumab, a humanized anti-respiratory syncytial virus monoclonal antibody, in adults and children JO - Antimicrob Agents Chemother VL - 56 UR - https://doi.org/10.1128/AAC.06446-11 DO - 10.1128/AAC.06446-11 ID - Robbie2012 ER - TY - JOUR PY - 2010 DA - 2010// TI - Respiratory syncytial virus activity - United States, July 2008-December 2009 JO - MMWR Morb Mortal Wkly Rep VL - 59 ID - ref24 ER - TY - JOUR AU - Stockman, L. J. AU - Curns, A. T. AU - Anderson, L. J. AU - Fischer-Langley, G. PY - 2012 DA - 2012// TI - Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997–2006 JO - Pediatr Inf Dis J VL - 31 UR - https://doi.org/10.1097/INF.0b013e31822e68e6 DO - 10.1097/INF.0b013e31822e68e6 ID - Stockman2012 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/13/334/prepub UR - http://www.biomedcentral.com/1471-2334/13/334/prepub ID - ref26 ER -